Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Recipharm Laboratories, Inc. 401(K) Plan is a benefit plan reported by Recipharm Laboratories, Inc. under EIN 56-2041552 and plan number 001. The latest loaded filing year is 2023. The filing reports 345 participants and $15,037,768 in end-of-year plan assets, where available in the loaded dataset.
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $15,037,768
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $15,037,768
- Net assets (BOY)
- $8,743,608
Income & contributions
- Employer contributions
- $1,800,209
- Participant contributions
- $2,609,874
- Total contributions
- $5,260,786
- Total income / additions
- $7,323,409
Expenses & distributions
- Benefits paid
- $974,835
- Administrative expenses
- $54,414
- Total expenses
- $1,029,249
- Net increase / (decrease)
- $6,294,160